Showing results (551-560 of 590) with videos related to
Sort By:
Pageof 59
Nature Biotechnology|July 22, 2026
Single-nucleus multimodal spatial transcriptomics reveals spatial colocalization of neoantigen-expressing tumor cells and cognate T cellsAdi Nagler, Amit Sud, Jack Y Ghannam, et al.Cancer Immunology Research|April 24, 2020
Mammalian SWI/SNF Complex Genomic Alterations and Immune Checkpoint Blockade in Solid TumorsSarah Abou Alaiwi, Amin H Nassar, Wanling Xie, et al.Cancer Cell|March 12, 2021
Progressive immune dysfunction with advancing disease stage in renal cell carcinomaDavid A Braun, Kelly Street, Kelly P Burke, et al.Nature Communications|January 21, 2023
Epigenomic charting and functional annotation of risk loci in renal cell carcinomaAmin H Nassar, Sarah Abou Alaiwi, Sylvan C Baca, et al.Nature Communications|May 13, 2022
MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targetsXintao Qiu, Nadia Boufaied, Tarek Hallal, et al.Nature Genetics|September 6, 2011
Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusionAdam J Bass, Michael S Lawrence, Lear E Brace, et al.Cancer Research|June 22, 2022
The Prostate Cancer Androgen Receptor Cistrome in African American Men Associates with Upregulation of Lipid Metabolism and Immune ResponseJacob E Berchuck, Elio Adib, Sarah Abou Alaiwi, et al.Cancer Research|February 6, 2021
ELOVL5 Is a Critical and Targetable Fatty Acid Elongase in Prostate CancerMargaret M Centenera, Julia S Scott, Jelle Machiels, et al.Nature Communications|September 27, 2019
High-fat diet fuels prostate cancer progression by rewiring the metabolome and amplifying the MYC programDavid P Labbé, Giorgia Zadra, Meng Yang, et al.Cell Reports|January 5, 2022
Integrative clinical and molecular characterization of translocation renal cell carcinomaZiad Bakouny, Ananthan Sadagopan, Praful Ravi, et al.Pageof 59